{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:07:08Z","timestamp":1789520828026,"version":"build-2803163510"},"reference-count":153,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20220818100015032"],"award-info":[{"award-number":["JCYJ20220818100015032"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009019","name":"Shenzhen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472781"],"award-info":[{"award-number":["82472781"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbcan.2026.189699","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:32Z","timestamp":1788307232000},"page":"189699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CARM1 in human cancer: a multifunctional epigenetic node driving tumor plasticity and therapeutic vulnerability"],"prefix":"10.1016","volume":"1881","author":[{"given":"Luyao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2008.12.013","article-title":"Protein arginine methylation in mammals: who, what, and why","volume":"33","author":"Bedford","year":"2009","journal-title":"Mol. Cell"},{"issue":"5423","key":"10.1016\/j.bbcan.2026.189699_bb0010","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1126\/science.284.5423.2174","article-title":"Regulation of transcription by a protein methyltransferase","volume":"284","author":"Chen","year":"1999","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.bbcan.2026.189699_bb0015","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1158\/0008-5472.CAN-24-3476","article-title":"CARM1-mediated MAP2K4 methylation potentiates the oncogenic functions of MAP2K4 and constitutes a targetable dependency in triple-negative breast cancer","volume":"85","author":"Kim","year":"2025","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189699_bb0020","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1038\/sj.emboj.7601855","article-title":"Functional insights from structures of coactivator-associated arginine methyltransferase 1 domains","volume":"26","author":"Troffer-Charlier","year":"2007","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189699_bb0025","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/s12276-025-01561-7","article-title":"Multifaceted roles of CARM1 beyond histone arginine methylation","volume":"57","author":"Cho","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189699_bb0030","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s13402-024-00943-9","article-title":"The emerging role of CARM1 in cancer","volume":"47","author":"Xie","year":"2024","journal-title":"Cell. Oncol. (Dordr)"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189699_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188916","article-title":"Unraveling the complexity of histone-arginine methyltransferase CARM1 in cancer: from underlying mechanisms to targeted therapeutics","volume":"1878","author":"Jin","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189699_bb0040","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tcb.2020.12.010","article-title":"CARM1\/PRMT4: making its mark beyond its function as a transcriptional coactivator","volume":"31","author":"Suresh","year":"2021","journal-title":"Trends Cell Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189699_bb0045","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/carcin\/bgt091","article-title":"PELP1 oncogenic functions involve CARM1 regulation","volume":"34","author":"Mann","year":"2013","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1158\/0008-5472.CAN-07-1983","article-title":"CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1","volume":"68","author":"Frietze","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.20327","article-title":"Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status","volume":"101","author":"Hong","year":"2004","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189699_bb0060","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0510842103","article-title":"Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells","volume":"103","author":"Baek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189699_bb0065","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/procel\/pwae010","article-title":"CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A","volume":"15","author":"Feng","year":"2024","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16010139","article-title":"Downregulated RBM5 enhances CARM1 expression and activates the PRKACA\/GSK3\u03b2 signaling pathway through alternative splicing-coupled nonsense-mediated decay","volume":"16","author":"Zhang","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189699_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102063","article-title":"A CRISPR-Cas9 library screening identifies CARM1 as a critical inhibitor of ferroptosis in hepatocellular carcinoma cells","volume":"34","author":"Cheng","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"36","key":"10.1016\/j.bbcan.2026.189699_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303484","article-title":"Inhibition of CARM1-mediated methylation of ACSL4 promotes Ferroptosis in colorectal Cancer","volume":"10","author":"Feng","year":"2023","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189699_bb0085","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jmb.2009.09.032","article-title":"CARM1 but not its enzymatic activity is required for transcriptional coactivation of NF-kappaB-dependent gene expression","volume":"394","author":"Jayne","year":"2009","journal-title":"J. Mol. Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189699_bb0090","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1101\/gad.568410","article-title":"CARM1 mediates the ligand-independent and tamoxifen-resistant activation of the estrogen receptor alpha by cAMP","volume":"24","author":"Carascossa","year":"2010","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0095","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1038\/s41467-021-25684-3","article-title":"Targeting the IRE1\u03b1\/XBP1s pathway suppresses CARM1-expressing ovarian cancer","volume":"12","author":"Lin","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189699_bb0100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00408-020-00324-7","article-title":"High expression of CARM1 inhibits lung cancer progression by targeting TP53 by regulating CTNNB1","volume":"198","author":"Hu","year":"2020","journal-title":"Lung"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189699_bb0105","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.molcel.2016.09.028","article-title":"Arginine methylation of MDH1 by CARM1 inhibits glutamine metabolism and suppresses pancreatic cancer","volume":"64","author":"Wang","year":"2016","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189699_bb0110","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1021\/acs.jmedchem.4c02106","article-title":"Small-molecule modulators targeting coactivator-associated arginine methyltransferase 1 (CARM1) as therapeutic agents for cancer treatment: current medicinal chemistry insights and emerging opportunities","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189699_bb0115","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.molcel.2020.12.010","article-title":"CARM1 regulates replication fork speed and stress response by stimulating PARP1","volume":"81","author":"Genois","year":"2021","journal-title":"Mol. Cell"},{"issue":"18","key":"10.1016\/j.bbcan.2026.189699_bb0120","doi-asserted-by":"crossref","first-page":"13028","DOI":"10.1021\/acs.jmedchem.3c00982","article-title":"Development of potent and selective coactivator-associated arginine methyltransferase 1 (CARM1) degraders","volume":"66","author":"Xie","year":"2023","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bbcan.2026.189699_bb0125","doi-asserted-by":"crossref","first-page":"13973","DOI":"10.1021\/acs.jmedchem.5c01022","article-title":"Development of a selective and potent PRMT4 PROTAC degrader with efficacy against multiple myeloma in vitro and in vivo","volume":"68","author":"Ju","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2026.189699_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15571","article-title":"Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition","volume":"8","author":"Shishkova","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189699_bb0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/BSR20080176","article-title":"Histone arginine methylations: their roles in chromatin dynamics and transcriptional regulation","volume":"29","author":"Litt","year":"2009","journal-title":"Biosci. Rep."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189699_bb0140","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.7150\/thno.39241","article-title":"A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor \u03b1-dependent transcriptional activation and breast carcinogenesis","volume":"10","author":"Peng","year":"2020","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189699_bb0145","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae068","article-title":"Protein arginine methyltransferase CARM1 in human breast cancer","volume":"165","author":"Bacabac","year":"2024","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbcan.2026.189699_bb0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1746-1596-8-129","article-title":"Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes","volume":"8","author":"Cheng","year":"2013","journal-title":"Diagn. Pathol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189699_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70386","article-title":"PRMT3 and CARM1: emerging epigenetic targets in Cancer","volume":"29","author":"Huang","year":"2025","journal-title":"J. Cell. Mol. Med."},{"issue":"21","key":"10.1016\/j.bbcan.2026.189699_bb0160","doi-asserted-by":"crossref","first-page":"12211","DOI":"10.1093\/nar\/gkab1122","article-title":"BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"6807","key":"10.1016\/j.bbcan.2026.189699_bb0165","doi-asserted-by":"crossref","DOI":"10.1126\/science.aea1200","article-title":"The CARM1 epigenetic enzyme inhibits cross-presenting dendritic cell function in cancer immunity","volume":"393","author":"Zhang","year":"2026","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189699_bb0170","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1158\/2159-8290.CD-20-1144","article-title":"CARM1 inhibition enables immunotherapy of resistant tumors by dual action on tumor cells and T cells","volume":"11","author":"Kumar","year":"2021","journal-title":"Cancer Discov."},{"issue":"5551","key":"10.1016\/j.bbcan.2026.189699_bb0175","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1126\/science.1065961","article-title":"A transcriptional switch mediated by cofactor methylation","volume":"294","author":"Xu","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0180","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1038\/s41467-024-47689-4","article-title":"Tyrosine phosphorylation of CARM1 promotes its enzymatic activity and alters its target specificity","volume":"15","author":"Itonaga","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/embo-reports\/kvf013","article-title":"Methylation at arginine 17 of histone H3 is linked to gene activation","volume":"3","author":"Bauer","year":"2002","journal-title":"EMBO Rep."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189699_bb0190","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1021\/acs.biochem.5b01071","article-title":"CARM1 preferentially methylates H3R17 over H3R26 through a random kinetic mechanism","volume":"55","author":"Jacques","year":"2016","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0195","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s10020-025-01388-y","article-title":"Context-specific applications of CARM1 inhibitors: functional profiles of EZM2302 and TP-064","volume":"31","author":"Cho","year":"2025","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189699_bb0200","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41418-022-01090-0","article-title":"ARID2 mitigates hepatic steatosis via promoting the ubiquitination of JAK2","volume":"30","author":"Cao","year":"2023","journal-title":"Cell Death Differ."},{"issue":"15","key":"10.1016\/j.bbcan.2026.189699_bb0205","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1073\/pnas.1114905109","article-title":"Histone H3R17me2a mark recruits human RNA polymerase-associated factor 1 complex to activate transcription","volume":"109","author":"Wu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189699_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000077","article-title":"Genic and global functions for Paf1C in chromatin modification and gene expression in Arabidopsis","volume":"4","author":"Oh","year":"2008","journal-title":"PLoS Genet."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189699_bb0215","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1097-2765(03)00091-1","article-title":"The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation","volume":"11","author":"Krogan","year":"2003","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189699_bb0220","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1073\/pnas.0812939106","article-title":"The Paf1 complex is required for efficient transcription elongation by RNA polymerase I","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189699_bb0225","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cell.2015.07.042","article-title":"PAF1, a molecular regulator of promoter-proximal pausing by RNA polymerase II","volume":"162","author":"Chen","year":"2015","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.bbcan.2026.189699_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm5504","article-title":"Coordinated regulation of RNA polymerase II pausing and elongation progression by PAF1","volume":"8","author":"Wang","year":"2022","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189699_bb0235","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf2468","article-title":"Enhancing HIV-1 latency reversal through regulating the elongating RNA Pol II pause-release by a small-molecule disruptor of PAF1C","volume":"9","author":"Soliman","year":"2023","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0240","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1186\/s12864-022-09013-6","article-title":"Transcriptomic profiling implicates PAF1 in both active and repressive immune regulatory networks","volume":"23","author":"Kenaston","year":"2022","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0245","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/s41467-024-45760-8","article-title":"PAF1c links S-phase progression to immune evasion and MYC function in pancreatic carcinoma","volume":"15","author":"Gaballa","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189699_bb0250","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2020.07.053","article-title":"RNA polymerase II-associated factor 1 regulates stem cell features of pancreatic cancer cells, independently of the PAF1 complex, via interactions with PHF5A and DDX3","volume":"159","author":"Karmakar","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189699_bb0255","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41388-021-02078-9","article-title":"Nup54-induced CARM1 nuclear importation promotes gastric cancer cell proliferation and tumorigenesis through transcriptional activation and methylation of Notch2","volume":"41","author":"Wang","year":"2022","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189699_bb0260","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.cell.2018.11.027","article-title":"CARM1 and paraspeckles regulate pre-implantation mouse embryo development","volume":"175","author":"Hupalowska","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189699_bb0265","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.18632\/aging.103280","article-title":"CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression","volume":"12","author":"Wu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbcan.2026.189699_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.678282","article-title":"Histone arginine methyltransferase CARM1-mediated H3R26me2 is essential for Morula-to-blastocyst transition in pigs","volume":"9","author":"Cao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0275","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cell.2016.02.032","article-title":"Long-lived binding of Sox2 to DNA predicts cell fate in the four-cell mouse embryo","volume":"165","author":"White","year":"2016","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189699_bb0280","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nsmb.2489","article-title":"Epigenetic programming and reprogramming during development","volume":"20","author":"Cantone","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"37","key":"10.1016\/j.bbcan.2026.189699_bb0285","doi-asserted-by":"crossref","first-page":"14894","DOI":"10.1073\/pnas.1312925110","article-title":"H3R42me2a is a histone modification with positive transcriptional effects","volume":"110","author":"Casadio","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189699_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034692","article-title":"A role for CARM1-mediated histone H3 arginine methylation in protecting histone acetylation by releasing corepressors from chromatin","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189699_bb0295","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.molcel.2010.11.024","article-title":"TDRD3 is an effector molecule for arginine-methylated histone marks","volume":"40","author":"Yang","year":"2010","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0300","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41467-025-55959-y","article-title":"Structural insights into human topoisomerase 3\u03b2 DNA and RNA catalysis and nucleic acid gate dynamics","volume":"16","author":"Yang","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189699_bb0305","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.molcel.2014.01.011","article-title":"Arginine methylation facilitates the recruitment of TOP3B to chromatin to prevent R loop accumulation","volume":"53","author":"Yang","year":"2014","journal-title":"Mol. Cell"},{"issue":"15","key":"10.1016\/j.bbcan.2026.189699_bb0310","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1093\/nar\/gkab642","article-title":"TDRD3 promotes DHX9 chromatin recruitment and R-loop resolution","volume":"49","author":"Yuan","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189699_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114537","article-title":"Arginine methylation-enabled FUS phase separation with SMN contributes to neuronal granule formation","volume":"43","author":"Wang","year":"2024","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189699_bb0320","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1097-2765(01)00244-1","article-title":"SMN, the product of the spinal muscular atrophy gene, binds preferentially to dimethylarginine-containing protein targets","volume":"7","author":"Friesen","year":"2001","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189699_bb0325","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1017\/S135583820101442X","article-title":"Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B\/B\u2019 and the Sm-like protein LSm4, and their interaction with the SMN protein","volume":"7","author":"Brahms","year":"2001","journal-title":"RNA"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189699_bb0330","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1042\/BST20221147","article-title":"Effectors and effects of arginine methylation","volume":"51","author":"Wang","year":"2023","journal-title":"Biochem. Soc. Trans."},{"issue":"35","key":"10.1016\/j.bbcan.2026.189699_bb0335","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202416809","article-title":"LEDGF binds H3R17me2a promoting de novo nucleotide biosynthesis in SETD2 mutant clear cell renal cell carcinoma","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189699_bb0340","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.stem.2012.07.001","article-title":"Carm1 regulates Pax7 transcriptional activity through MLL1\/2 recruitment during asymmetric satellite stem cell divisions","volume":"11","author":"Kawabe","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0345","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1038\/s41467-021-21963-1","article-title":"Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189699_bb0350","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1093\/nar\/gkae329","article-title":"CARM1 hypermethylates the NuRD chromatin remodeling complex to promote cell cycle gene expression and breast cancer development","volume":"52","author":"Chen","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189699_bb0355","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/S0960-9822(02)01387-8","article-title":"Crosstalk between CARM1 methylation and CBP acetylation on histone H3","volume":"12","author":"Daujat","year":"2002","journal-title":"Curr. Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189699_bb0360","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.molcel.2017.07.026","article-title":"Structural and functional impacts of ER coactivator sequential recruitment","volume":"67","author":"Yi","year":"2017","journal-title":"Mol. Cell"},{"issue":"32","key":"10.1016\/j.bbcan.2026.189699_bb0365","doi-asserted-by":"crossref","first-page":"28927","DOI":"10.1074\/jbc.M502173200","article-title":"Coactivator-associated arginine methyltransferase 1, CARM1, affects pre-mRNA splicing in an isoform-specific manner","volume":"280","author":"Ohkura","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0370","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.molcel.2006.11.019","article-title":"The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing","volume":"25","author":"Cheng","year":"2007","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189699_bb0375","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/embo-reports\/kvf052","article-title":"PABP1 identified as an arginine methyltransferase substrate using high-density protein arrays","volume":"3","author":"Lee","year":"2002","journal-title":"EMBO Rep."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189699_bb0380","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrm2838","article-title":"The mechanism of eukaryotic translation initiation and principles of its regulation","volume":"11","author":"Jackson","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189699_bb0385","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1042\/BJ20111474","article-title":"The multifunctional poly(A)-binding protein (PABP) 1 is subject to extensive dynamic post-translational modification, which molecular modelling suggests plays an important role in co-ordinating its activities","volume":"441","author":"Brook","year":"2012","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0390","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41419-025-07416-3","article-title":"PSMD14-mediated deubiquitination of CARM1 facilitates the proliferation and metastasis of hepatocellular carcinoma by inducing the transcriptional activation of FERMT1","volume":"16","author":"Lu","year":"2025","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189699_bb0395","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1369","article-title":"Arginine methylation of PPP1CA by CARM1 regulates glucose metabolism and affects osteogenic differentiation and osteoclastic differentiation","volume":"13","author":"Zhang","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"15","key":"10.1016\/j.bbcan.2026.189699_bb0400","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.7150\/ijms.62467","article-title":"PRMT4 promotes hepatocellular carcinoma progression by activating AKT\/mTOR signaling and indicates poor prognosis","volume":"18","author":"Du","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbcan.2026.189699_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151827","article-title":"TRIB3 recruits and stabilizes CARM1 to confer chemoresistance by activating Akt signalling in clear cell renal cancer cells","volume":"766","author":"Hu","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189699_bb0410","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1101\/gad.1975811","article-title":"Regulated recruitment of tumor suppressor BRCA1 to the p21 gene by coactivator methylation","volume":"25","author":"Lee","year":"2011","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189699_bb0415","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccell.2019.12.015","article-title":"EZH2 inhibition sensitizes CARM1-high, homologous recombination proficient ovarian cancers to PARP inhibition","volume":"37","author":"Karakashev","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0420","article-title":"The biological essence of synthetic lethality: bringing new opportunities for cancer therapy","volume":"3","author":"Ge","year":"2024","journal-title":"MedComm. Oncol."},{"issue":"6330","key":"10.1016\/j.bbcan.2026.189699_bb0425","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0430","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41467-018-03031-3","article-title":"CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity","volume":"9","author":"Karakashev","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189699_bb0435","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nm.3799","article-title":"Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers","volume":"21","author":"Bitler","year":"2015","journal-title":"Nat. Med."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189699_bb0440","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1158\/0008-5472.CAN-21-1545","article-title":"Targeting the IRE1\u03b1\/XBP1 endoplasmic reticulum stress response pathway in ARID1A-mutant ovarian cancers","volume":"81","author":"Zundell","year":"2021","journal-title":"Cancer Res."},{"issue":"Supplement 1, 2","key":"10.1016\/j.bbcan.2026.189699_bb0445","article-title":"Arginine methylation of BRD4 by CARM1 regulates its function in AML","volume":"142","author":"Mookhtiar","year":"2023","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189699_bb0450","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.molcel.2018.03.006","article-title":"JMJD6 licenses ER\u03b1-dependent enhancer and coding gene activation by modulating the recruitment of the CARM1\/MED12 co-activator complex","volume":"70","author":"Gao","year":"2018","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189699_bb0455","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.celrep.2013.11.025","article-title":"PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complex","volume":"5","author":"Vu","year":"2013","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189699_bb0460","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0465","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1476-4598-12-40","article-title":"Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity","volume":"12","author":"Davis","year":"2013","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189699_bb0470","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/febs.17097","article-title":"NEAT1 repression by MED12 creates chemosensitivity in p53 wild-type breast cancer cells","volume":"291","author":"Zhang","year":"2024","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0475","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccr.2013.12.007","article-title":"CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis","volume":"25","author":"Wang","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189699_bb0480","series-title":"Prostate Cancer","article-title":"Theranostics in metastatic castrate resistant prostate cancer","author":"Vorster","year":"2021"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0485","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc3409","article-title":"Protein arginine methyltransferases and cancer","volume":"13","author":"Yang","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189699_bb0490","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endrev\/bnab002","article-title":"Hormonal therapy for prostate Cancer","volume":"42","author":"Desai","year":"2021","journal-title":"Endocr. Rev."},{"issue":"39","key":"10.1016\/j.bbcan.2026.189699_bb0495","doi-asserted-by":"crossref","first-page":"15710","DOI":"10.1073\/pnas.1218168110","article-title":"Inhibition of androgen receptor and \u03b2-catenin activity in prostate cancer","volume":"110","author":"Lee","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"36","key":"10.1016\/j.bbcan.2026.189699_bb0500","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027094","article-title":"The protein arginine methyltransferases (PRMTs) PRMT1 and CARM1 as candidate epigenetic drivers in prostate cancer progression","volume":"100","author":"Grypari","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbcan.2026.189699_bb0505","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1471-2407-10-197","article-title":"Differential CARM1 expression in prostate and colorectal cancers","volume":"10","author":"Kim","year":"2010","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189699_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052049","article-title":"Lung Cancer-epidemiology, pathogenesis, treatment and molecular aspect (review of literature)","volume":"26","author":"Smolarz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189699_bb0515","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1200\/JCO.2012.46.9270","article-title":"New pathologic classification of lung cancer: relevance for clinical practice and clinical trials","volume":"31","author":"Travis","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189699_bb0520","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.biochi.2013.10.021","article-title":"CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features","volume":"97","author":"Elakoum","year":"2014","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0525","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41467-023-35864-y","article-title":"The NFIB\/CARM1 partnership is a driver in preclinical models of small cell lung cancer","volume":"14","author":"Gao","year":"2023","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189699_bb0530","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1101\/gad.2046711","article-title":"Nuclear factor I\/B is an oncogene in small cell lung cancer","volume":"25","author":"Dooley","year":"2011","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189699_bb0535","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.celrep.2016.06.020","article-title":"Transcription factor NFIB is a driver of small cell lung cancer progression in mice and marks metastatic disease in patients","volume":"16","author":"Semenova","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189699_bb0540","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2147\/DDDT.S228123","article-title":"Gallic acid impedes non-small cell lung cancer progression via suppression of EGFR-dependent CARM1-PELP1 complex","volume":"14","author":"Wang","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0545","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev. Cell"},{"issue":"15","key":"10.1016\/j.bbcan.2026.189699_bb0550","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1101\/gad.14.15.1837","article-title":"Wnt signaling and cancer","volume":"14","author":"Polakis","year":"2000","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189699_bb0555","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063178","article-title":"PI3K\/Akt\/mTOR signaling pathway as a target for colorectal cancer treatment","volume":"25","author":"Leiphrakpam","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0560","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","article-title":"Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189699_bb0565","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1158\/1541-7786.MCR-10-0223","article-title":"A coactivator role of CARM1 in the dysregulation of \u03b2-catenin activity in colorectal cancer cell growth and gene expression","volume":"9","author":"Ou","year":"2011","journal-title":"Mol. Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189699_bb0570","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.7150\/ijbs.41230","article-title":"The CARM1-p300-c-Myc-max (CPCM) transcriptional complex regulates the expression of CUL4A\/4B and affects the stability of CRL4 E3 ligases in colorectal cancer","volume":"16","author":"Lu","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189699_bb0575","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.130217","article-title":"CUL4A ubiquitin ligase: a promising drug target for cancer and other human diseases","volume":"4","author":"Sharma","year":"2014","journal-title":"Open Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189699_bb0580","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3892\/or.2013.2651","article-title":"Elevated expression of coactivator-associated arginine methyltransferase 1 is associated with early hepatocarcinogenesis","volume":"30","author":"Osada","year":"2013","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189699_bb0585","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1016\/j.celrep.2018.08.066","article-title":"CARM1 Methylates GAPDH to regulate glucose metabolism and is suppressed in liver cancer","volume":"24","author":"Zhong","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189699_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110772","article-title":"CircHULC accelerates the growth of human liver cancer stem cells by enhancing chromatin reprogramming and chromosomal instability via autophagy","volume":"109","author":"Song","year":"2023","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0595","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41420-024-02244-4","article-title":"Arginine methylation-dependent TRIM47 stability mediated by CARM1 promotes the metastasis of hepatocellular carcinoma","volume":"10","author":"Tang","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189699_bb0600","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189699_bb0605","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1007\/s11033-023-08645-5","article-title":"Inhibition of CARM1 suppresses proliferation of multiple myeloma cells through activation of p53 signaling pathway","volume":"50","author":"Yang","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0610","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10238-025-01624-z","article-title":"N6-methyladenosine-mediated upregulation of H19 promotes resistance to bortezomib by modulating the miR-184\/CARM1 axis in multiple myeloma","volume":"25","author":"Wang","year":"2025","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0615","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18446-z","article-title":"Identification of a CARM1 inhibitor with potent in vitro and in vivo activity in preclinical models of multiple myeloma","volume":"7","author":"Drew","year":"2017","journal-title":"Sci. Rep."},{"issue":"26","key":"10.1016\/j.bbcan.2026.189699_bb0620","doi-asserted-by":"crossref","first-page":"18480","DOI":"10.18632\/oncotarget.24883","article-title":"TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma","volume":"9","author":"Nakayama","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189699_bb0625","article-title":"A novel combination approach targeting P300 and DNA-PK exploits epigenetic dependencies in acute myeloid leukemia","volume":"34","author":"Saladi","year":"2026","journal-title":"Mol. Ther. Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189699_bb0630","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1038\/s41375-020-0908-8","article-title":"CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP\/EP300-mutated lymphomas","volume":"34","author":"Veazey","year":"2020","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189699_bb0635","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ccell.2018.05.007","article-title":"CARM1 is essential for myeloid leukemogenesis but dispensable for normal hematopoiesis","volume":"33","author":"Greenblatt","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189699_bb0640","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00003086-199006000-00013","article-title":"Tumors about the knee in children","volume":"255","author":"Gebhardt","year":"1990","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189699_bb0645","doi-asserted-by":"crossref","first-page":"976","DOI":"10.7150\/ijbs.19191","article-title":"The overexpression of CARM1 promotes human osteosarcoma cell proliferation through the pGSK3\u03b2\/\u03b2-catenin\/cyclinD1 signaling pathway","volume":"13","author":"Li","year":"2017","journal-title":"Int. J. Biol. Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189699_bb0650","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1111\/cas.16295","article-title":"Blocking CXCR4-CARM1-YAP axis overcomes osteosarcoma doxorubicin resistance by suppressing aerobic glycolysis","volume":"115","author":"Li","year":"2024","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0655","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1038\/s41467-022-33786-9","article-title":"ESRP1-regulated isoform switching of LRRFIP2 determines metastasis of gastric cancer","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0660","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12935-022-02522-0","article-title":"CARM1 promotes gastric cancer progression by regulating TFE3 mediated autophagy enhancement through the cytoplasmic AMPK-mTOR and nuclear AMPK-CARM1-TFE3 signaling pathways","volume":"22","author":"Yang","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189699_bb0665","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41419-024-07052-3","article-title":"The NRF2-CARM1 axis links glucose sensing to transcriptional and epigenetic regulation of the pentose phosphate pathway in gastric cancer","volume":"15","author":"Ping","year":"2024","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189699_bb0670","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/2767-9764.CRC-23-0030","article-title":"Targeting fatty acid reprogramming suppresses CARM1-expressing ovarian Cancer","volume":"3","author":"Lombardi","year":"2023","journal-title":"Cancer Res. Commun."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189699_bb0675","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1158\/0008-5472.CAN-10-2426","article-title":"CARM1 is an important determinant of ER\u03b1-dependent breast cancer cell differentiation and proliferation in breast cancer cells","volume":"71","author":"Al-Dhaheri","year":"2011","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0680","doi-asserted-by":"crossref","DOI":"10.3892\/or.2023.8670","article-title":"RPF2 mediates the CARM1-MYCN axis to promote chemotherapy resistance in colorectal cancer cells","volume":"51","author":"Lu","year":"2024","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2026.189699_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156242","article-title":"C-C motif chemokines ligand 7 contributes to metabolic dysfunction-associated steatotic liver disease by enabling redox-sensitive induction of hypermethylated in cancer 1","volume":"168","author":"Sun","year":"2025","journal-title":"Metabolism"},{"issue":"42","key":"10.1016\/j.bbcan.2026.189699_bb0690","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2213718119","article-title":"LYL1 facilitates AETFC assembly and gene activation by recruiting CARM1 in t(8,21) AML","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Supplement 1","key":"10.1016\/j.bbcan.2026.189699_bb0695","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1182\/blood-2023-189759","article-title":"Arginine methylation of BRD4 by CARM1 regulates its function in AML","volume":"142","author":"Mookhtiar","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2026.189699_bb0700","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.545934","article-title":"Proteome-wide alterations of asymmetric arginine dimethylation associated with pancreatic ductal adenocarcinoma pathogenesis","volume":"8","author":"Wei","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0705","article-title":"Expression of pluripotency-related genes in human glioblastoma","volume":"4","author":"Rios \u00c1","year":"2022","journal-title":"Neurooncol. Adv."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189699_bb0710","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1074\/jbc.M109.035865","article-title":"Enzymatic activity is required for the in vivo functions of CARM1","volume":"285","author":"Kim","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189699_bb0715","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbrc.2022.01.090","article-title":"Ribosome production factor 2 homolog promotes migration and invasion of colorectal cancer cells by inducing epithelial-mesenchymal transition via AKT\/Gsk-3\u03b2 signaling pathway","volume":"597","author":"Li","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189699_bb0720","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.scib.2019.05.024","article-title":"TRIM28 protects CARM1 from proteasome-mediated degradation to prevent colorectal cancer metastasis","volume":"64","author":"Cui","year":"2019","journal-title":"Sci. Bull."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189699_bb0725","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41419-025-07533-z","article-title":"CARM1 S217 phosphorylation by CDK1 in late G2 phase facilitates mitotic entry","volume":"16","author":"Cho","year":"2025","journal-title":"Cell Death Dis."},{"issue":"45","key":"10.1016\/j.bbcan.2026.189699_bb0730","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202502800","article-title":"An epigenetic Nanoagonist facilitates T cell priming, recruitment, and reinvigoration in tumors resistant to PD-L1 therapy","volume":"37","author":"Zhao","year":"2025","journal-title":"Adv. Mater."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189699_bb0735","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1021\/acs.jmedchem.6b00668","article-title":"Discovery of a potent and selective coactivator associated arginine methyltransferase 1 (CARM1) inhibitor by virtual screening","volume":"59","author":"Ferreira de Freitas","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2026.189699_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116288","article-title":"Structure-based discovery of potent CARM1 inhibitors for colorectal cancer therapy","volume":"269","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbcan.2026.189699_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2026.108105","article-title":"A CARM1-targeted therapeutic peptide suppresses breast cancer progression both in vitro and in vivo","volume":"224","author":"Peng","year":"2026","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189699_bb0750","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1021\/acs.jmedchem.9b00297","article-title":"Design and synthesis of potent, selective inhibitors of protein arginine methyltransferase 4 against acute myeloid leukemia","volume":"62","author":"Guo","year":"2019","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189699_bb0755","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"22","key":"10.1016\/j.bbcan.2026.189699_bb0760","doi-asserted-by":"crossref","first-page":"16650","DOI":"10.1021\/acs.jmedchem.1c01308","article-title":"Structure-based discovery of potent CARM1 inhibitors for solid tumor and cancer immunology therapy","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2026.189699_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177350","article-title":"Targeting protein arginine methyltransferases in breast cancer: promising strategies","volume":"992","author":"Wei","year":"2025","journal-title":"Eur. J. Pharmacol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X2600171X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X2600171X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:20:42Z","timestamp":1789518042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X2600171X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":153,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0304419X2600171X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189699","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CARM1 in human cancer: a multifunctional epigenetic node driving tumor plasticity and therapeutic vulnerability","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189699"}}